Cargando…

Serum Cortisol Concentrations in Dogs with Pituitary‐Dependent Hyperadrenocorticism and Atypical Hyperadrenocorticism

BACKGROUND: Atypical hyperadrenocorticism (AHAC) is considered when dogs have clinical signs of hypercortisolemia with normal hyperadrenocorticism screening tests. HYPOTHESIS/OBJECTIVES: To compare cortisol concentrations and adrenal gland size among dogs with pituitary‐dependent hyperadrenocorticis...

Descripción completa

Detalles Bibliográficos
Autores principales:	Frank, L.A., Henry, G.A., Whittemore, J.C., Enders, B.D., Mawby, D.I., Rohrbach, B.W.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2014
Materias:	Standard Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4858107/ https://www.ncbi.nlm.nih.gov/pubmed/25411029 http://dx.doi.org/10.1111/jvim.12500

Ejemplares similares

Canine Pancreatic‐Specific Lipase Concentrations in Clinically Healthy Dogs and Dogs with Naturally Occurring Hyperadrenocorticism
por: Mawby, D.I., et al.
Publicado: (2014)

Serum Adipokine Concentrations in Dogs with Naturally Occurring Pituitary‐Dependent Hyperadrenocorticism
por: Cho, K.‐D., et al.
Publicado: (2013)

Effect of Trilostane on Hormone and Serum Electrolyte Concentrations in Dogs with Pituitary‐Dependent Hyperadrenocorticism
por: Griebsch, C., et al.
Publicado: (2013)

Effect of Trilostane and Mitotane on Aldosterone Secretory Reserve in Dogs with Pituitary‐Dependent Hyperadrenocorticism
por: Reid, L.E., et al.
Publicado: (2014)

Cortisol Concentrations in Well‐Regulated Dogs with Hyperadrenocorticism Treated with Trilostane
por: Midence, J.N., et al.
Publicado: (2015)

Clinical Findings, Diagnostic Test Results, and Treatment Outcome in Cats with Spontaneous Hyperadrenocorticism: 30 Cases
por: Valentin, S.Y., et al.
Publicado: (2014)

The interpretive contribution of the baseline serum cortisol concentration of the ACTH stimulation test in the diagnosis of pituitary dependent hyperadrenocorticism in dogs
por: Nivy, Ran, et al.
Publicado: (2018)

Relationship of serum leptin concentration with pituitary‐dependent hyperadrenocorticism and cholestatic disease in dogs
por: Lee, S., et al.
Publicado: (2019)

Long‐Term Survival of Dogs with Adrenal‐Dependent Hyperadrenocorticism: A Comparison between Mitotane and Twice Daily Trilostane Treatment
por: Arenas, C., et al.
Publicado: (2014)

Laboratory assessment of trilostane treatment in dogs with pituitary‐dependent hyperadrenocorticism
por: Arenas Bermejo, Carolina, et al.
Publicado: (2020)

Carbenoxolone Disodium Treatment for Canine Pituitary-Dependent Hyperadrenocorticism
por: Teshima, Takahiro, et al.
Publicado: (2016)

Comparison of Adrenocorticotropic Hormone Stimulation Test Results Started 2 versus 4 Hours after Trilostane Administration in Dogs with Naturally Occurring Hyperadrenocorticism
por: Bonadio, C.M., et al.
Publicado: (2014)

Skin fragility in a cat presenting with pituitary-dependent hyperadrenocorticism
por: Hardy, Lorna, et al.
Publicado: (2023)

Trismus due to myotonia associated with hyperadrenocorticism in a dog
por: YOKOTA, Shunya, et al.
Publicado: (2023)

Utility of a corticotropin‐releasing hormone test to differentiate pituitary‐dependent hyperadrenocorticism from cortisol‐producing adrenal tumors in dogs
por: Tanaka, Sachiyo, et al.
Publicado: (2021)

Suspected spontaneous hyperadrenocorticism in a young experimental beagle dog
por: Obara, Ryo D., et al.
Publicado: (2021)

The effect of 1 year of trilostane treatment on peripheral lymphocyte subsets in dogs with pituitary-dependent hyperadrenocorticism
por: ODA, Hitomi, et al.
Publicado: (2016)

Pituitary-dependent hyperadrenocorticism and generalised toxoplasmosis in a cat with neurological signs
por: Spada, Eva, et al.
Publicado: (2010)

Case report: Central-pituitary hypothyroidism concurrent with hyperadrenocorticism without pituitary macroadenoma in a Miniature Schnauzer dog
por: Chae, Yeon, et al.
Publicado: (2023)

Quantitative CT assessment of bone mineral density in dogs with hyperadrenocorticism
por: Lee, Donghoon, et al.
Publicado: (2015)

Ultrasonographic evaluation of skin thickness in small breed dogs with hyperadrenocorticism
por: Heo, Seonghun, et al.
Publicado: (2018)

Successful treatment of occult hyperadrenocorticism with mitotane but not trilostane in a dog
por: Park, Su‐Min, et al.
Publicado: (2021)

Evaluation of compounded trilostane packets for dogs with naturally occurring hyperadrenocorticism
por: Nam, Sookin, et al.
Publicado: (2021)

Bioequivalence of Orally Administered Generic, Compounded, and Innovator‐Formulated Itraconazole in Healthy Dogs
por: Mawby, D.I., et al.
Publicado: (2013)

Associations among systemic blood pressure, microalbuminuria and albuminuria in dogs affected with pituitary- and adrenal-dependent hyperadrenocorticism
por: Lien, Yu-Hsin, et al.
Publicado: (2010)

Clinical Relationship between Cholestatic Disease and Pituitary‐Dependent Hyperadrenocorticism in Dogs: A Retrospective Case Series
por: Kim, K.‐h., et al.
Publicado: (2017)

Changes in systolic blood pressure in dogs with pituitary dependent hyperadrenocorticism during the first year of trilostane treatment
por: García San José, Paula, et al.
Publicado: (2020)

Three Cases of Transtracheal Catheter Oxygenation for Postoperative Dyspnoea with Pituitary-Dependent Hyperadrenocorticism in Dogs Treated by Surgery
por: Tanaka, Sachiyo, et al.
Publicado: (2022)

Antibody Response to Canine Parvovirus Vaccination in Dogs with Hyperadrenocorticism Treated with Trilostane
por: Bergmann, Michèle, et al.
Publicado: (2020)

Prevalence and risk factors associated with systemic hypertension in dogs with spontaneous hyperadrenocorticism
por: García San José, Paula, et al.
Publicado: (2020)

Erratum for “Evaluation of compounded trilostane packets for dogs with naturally occurring hyperadrenocorticism”
Publicado: (2022)

An activating mutation in the CRHR1 gene is rarely associated with pituitary-dependent hyperadrenocorticism in poodles
por: De-Marco, Viviani, et al.
Publicado: (2017)

Serum Bile Acids Concentrations and Liver Enzyme Activities after Low-Dose Trilostane in Dogs with Hyperadrenocorticism
por: Tinted, Nannicha, et al.
Publicado: (2023)

Comparison of 2 Doses for ACTH Stimulation Testing in Dogs Suspected of or Treated for Hyperadrenocorticism
por: Aldridge, C., et al.
Publicado: (2016)

Diabetes mellitus remission in a cat with pituitary-dependent hyperadrenocorticism after trilostane treatment
por: Muschner, Adriana Cunha, et al.
Publicado: (2018)

Serum steroid profiling of hepatocellular carcinoma associated with hyperadrenocorticism in dogs: A preliminary study
por: Oo, Thandar, et al.
Publicado: (2022)

Metformin reduces insulin resistance and the tendency toward hyperglycaemia and dyslipidaemia in dogs with hyperadrenocorticism
por: Miceli, Diego Daniel, et al.
Publicado: (2018)

Erratum for Prevalence and risk factors associated with systemic hypertension in dogs with spontaneous hyperadrenocorticism
Publicado: (2020)

Survival analysis of 219 dogs with hyperadrenocorticism attending primary care practice in England
por: Schofield, Imogen, et al.
Publicado: (2020)

Decrease of nitric oxide and increase in diastolic blood pressure are two events that affect renal function in dogs with pituitary dependent hyperadrenocorticism
por: Vidal, Patricia N., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_miog6ngg36nvr7dkiq3ebuik89